Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions].

Related Keywords

United States ,American ,Jon Miller ,Andrea Corcoran ,Maxwell Skor ,Janet Hammond ,John Vavricka ,Arantxa Horga ,Deric Joseph ,Jonae Barnes ,Jean Pierre Sommadossi ,Jonathan Miller ,Roanna Ruiz ,Atea Pharmaceuticals ,Morgan Stanley ,Corporate Communications At Atea Pharmaceuticals ,Atea Pharmaceuticals Inc ,Atea Pharmaceuticals Third Quarter ,Exchange Commission ,Nasdaq ,Call Transcript November ,Business Update Conference ,Senior Vice President ,Investor Relations ,Corporate Communications ,Chief Executive Officer ,Chief Development Officer ,Chief Medical Officer ,Chief Financial Officer ,Executive Vice President ,Chief Commercial Officer ,Pierre Sommadossi ,American Association ,Liver Diseases ,Real Estate ,American Stocks To Buy Heading ,